Earlier this morning, REGENXBIO released financial and operating results for the third quarter ended September 30, 2025.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that ...
PHOENIX — Jace Taylor is a rambunctious 4-year-old boy. He runs, jumps and plays with his friends. He isn’t aware that genetically, he’s different from other children. “I think he’s too young to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback